Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 15, 2017
The impact of FDA regulatory activities on incident dispensing of LABA-containing medication: 2005-2011Meghan A Baker, Melissa G Butler, Sally Seymour, et al.
JAMA Network Open|February 13, 2025
Physician Experiences With and Perspectives on Clozapine PrescribingAmeet Sarpatwari, Zhigang Lu, Massimiliano Russo, et al.
The Journal of Allergy and Clinical Immunology|January 5, 2016
Changing patterns of asthma medication use related to US Food and Drug Administration long-acting β2-agonist regulation from 2005-2011Melissa G Butler, Esther H Zhou, Fang Zhang, et al.
Epidemiology (Cambridge, Mass.)|October 1, 2019
Use of Time-Dependent Propensity Scores to Adjust Hazard Ratio Estimates in Cohort Studies with Differential Depletion of SusceptiblesRichard Wyss, Joshua J Gagne, Yueqin Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Radiotherapy and survival in prostate cancer patients: a population-based studyEsther H Zhou, Rodney J Ellis, Edward Cherullo, et al.
Clinical Pharmacology and Therapeutics|October 11, 2025
Patient Perceptions of and Experiences with Risk Evaluation and Mitigation StrategiesAmeet Sarpatwari, Su Been Lee, Heidi Zakoul, et al.
Clinical Pharmacology and Therapeutics|February 20, 2024
How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of PhysiciansAmeet Sarpatwari, Zhigang Lu, Massimiliano Russo, et al.
Drug Safety|April 17, 2026
Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) ToolYanning Wang, Celeste L Y Ewig, Nicole E Smolinski, et al.
BMJ Mental Health|July 10, 2026
Prevalence and frequency of haematological testing in patients initiating clozapine in the USAKatsiaryna Bykov, Mufaddal Mahesri, Krista F Huybrechts, et al.
JMIR Public Health and Surveillance|January 7, 2018
Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods AnalysisMichael S Sinha, Clark C Freifeld, John S Brownstein, et al.
Pageof 5